Related Experiment Video
Updated: Dec 16, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
The Molecular Landscape of Hürthle Cell Thyroid Cancer Is Associated with Altered Mitochondrial Function-A
Sonam Kumari1, Ruth Adewale1, Joanna Klubo-Gwiezdzinska1
1Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Hürthle cell thyroid carcinoma (HTC) accounts for 3-5% of all thyroid malignancies. Widely invasive HTC is characterized by poor prognosis and limited responsiveness to standard therapy with radioiodine. The molecular landscape of HTC is significantly different from the genetic signature seen in other forms of thyroid cancer. We performed a comprehensive literature review on the association between the molecular features of HTC and cancer metabolism. We searched the Pubmed, Embase, and Medline databases for clinical and translational studies published between 1980 and 2020 in English, coupling "HTC" with the following keywords: "genomic analysis", "mutations", "exome sequencing", "molecular", "mitochondria", "metabolism", "oxidative phosphorylation", "glycolysis", "oxidative stress", "reactive oxygen species", and "oncogenes". HTC is characterized by frequent complex I mitochondrial DNA mutations as early clonal events. This genetic signature is associated with the abundance of malfunctioning mitochondria in cancer cells. HTC relies predominantly on aerobic glycolysis as a source of energy production, as oxidative phosphorylation-related genes are downregulated. The enhanced glucose utilization by HTC is used for diagnostic purposes in the clinical setting for the detection of metastases by fluorodeoxyglucose positron emission tomography (FGD-PET/CT) imaging. A comprehensive metabolomic profiling of HTC in association with its molecular landscape might be necessary for the implementation of tumor-specific therapeutic approaches.
Insights
Hürthle cell thyroid carcinoma (HTC) exhibits unique mitochondrial DNA mutations and relies on aerobic glycolysis for energy. Understanding HTC
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Hürthle cell thyroid carcinoma (HTC) represents 3-5% of thyroid cancers, often presenting with aggressive behavior and poor response to radioiodine therapy.
- The molecular profile of HTC diverges significantly from other thyroid cancer subtypes, suggesting distinct oncogenic pathways.
- Mitochondrial dysfunction and altered cellular metabolism are increasingly recognized as hallmarks of cancer.
Purpose of the Study:
- To conduct a comprehensive literature review on the molecular features of HTC and their association with cancer metabolism.
- To elucidate the specific metabolic dependencies and genetic underpinnings of HTC.
- To identify potential therapeutic targets based on the unique molecular and metabolic landscape of HTC.
Main Methods:
- Systematic literature search of PubMed, Embase, and Medline databases (1980-2020).
- Keywords included "HTC", "genomic analysis", "mutations", "exome sequencing", "molecular", "mitochondria", "metabolism", "oxidative phosphorylation", "glycolysis", "oxidative stress", "reactive oxygen species", and "oncogenes".
- Review focused on clinical and translational studies linking molecular characteristics to metabolic pathways in HTC.
Main Results:
- HTC frequently harbors complex I mitochondrial DNA mutations as early genetic events, leading to mitochondrial dysfunction.
- HTC predominantly utilizes aerobic glycolysis for energy production, with downregulated oxidative phosphorylation-related genes.
- Enhanced glucose uptake in HTC is exploited for diagnostic imaging, such as fluorodeoxyglucose positron emission tomography (FGD-PET/CT).
Conclusions:
- The distinct molecular signature of HTC, characterized by mitochondrial DNA mutations and a glycolytic phenotype, differentiates it from other thyroid cancers.
- Targeting the specific metabolic pathways of HTC may offer novel therapeutic strategies.
- Further metabolomic profiling integrated with molecular data is crucial for developing personalized treatments for HTC.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Mitochondria
The Inner Mitochondrial Membrane
Animal Mitochondrial Genetics

